VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.

Standard

VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. / Murck, H; Guldner, J; Colla-Müller, M; Frieboes, R M; Schier, T; Wiedemann, Klaus; Holsboer, F; Steiger, A.

in: AM J PHYSIOL-HEART C, Jahrgang 271(4 Pt 2), 1996, S. 905-911.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Murck, H, Guldner, J, Colla-Müller, M, Frieboes, RM, Schier, T, Wiedemann, K, Holsboer, F & Steiger, A 1996, 'VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.', AM J PHYSIOL-HEART C, Jg. 271(4 Pt 2), S. 905-911. <http://www.ncbi.nlm.nih.gov/pubmed/8897980?dopt=Citation>

APA

Murck, H., Guldner, J., Colla-Müller, M., Frieboes, R. M., Schier, T., Wiedemann, K., Holsboer, F., & Steiger, A. (1996). VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. AM J PHYSIOL-HEART C, 271(4 Pt 2), 905-911. http://www.ncbi.nlm.nih.gov/pubmed/8897980?dopt=Citation

Vancouver

Murck H, Guldner J, Colla-Müller M, Frieboes RM, Schier T, Wiedemann K et al. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. AM J PHYSIOL-HEART C. 1996;271(4 Pt 2):905-911.

Bibtex

@article{ddf00c9487924a4db93103c26259d7f3,
title = "VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.",
abstract = "Centrally administered vasoactive intestinal polypeptide (VIP) promotes rapid eye movement (REM) sleep in rats, rabbits, and cats. We studied the effect of 4 x 10 micrograms VIP (expt 1, n = 7) and 4 x 50 micrograms VIP (expt 2, n = 10) administered hourly as intravenous boluses between 2200 and 0100 on sleep electroencephalogram and secretion of plasma adreno corticotropic hormone, cortisol, growth hormone, and prolactin in humans. In experiment 2, the sleep cycles were decelerated during the first three cycles because of increased duration of both REM and non-REM sleep periods, and there was a tendency to increased REM-to-non-REM ratios. With a low VIP dose, prolactin levels were decreased during the whole night, whereas, with a high dose, they were increased during the first half of the night. In experiment 2, the cortisol nadir was advanced, after midnight the serum cortisol levels were enhanced, and the growth hormone peak was blunted. It appears that VIP may have a phase-advancing effect on sleep cycles and cortisol secretion, possibly through actions that involve the suprachiasmatic nucleus.",
author = "H Murck and J Guldner and M Colla-M{\"u}ller and Frieboes, {R M} and T Schier and Klaus Wiedemann and F Holsboer and A Steiger",
year = "1996",
language = "Deutsch",
volume = "271(4 Pt 2)",
pages = "905--911",
journal = "AM J PHYSIOL-HEART C",
issn = "0363-6135",
publisher = "American Physiological Society",

}

RIS

TY - JOUR

T1 - VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.

AU - Murck, H

AU - Guldner, J

AU - Colla-Müller, M

AU - Frieboes, R M

AU - Schier, T

AU - Wiedemann, Klaus

AU - Holsboer, F

AU - Steiger, A

PY - 1996

Y1 - 1996

N2 - Centrally administered vasoactive intestinal polypeptide (VIP) promotes rapid eye movement (REM) sleep in rats, rabbits, and cats. We studied the effect of 4 x 10 micrograms VIP (expt 1, n = 7) and 4 x 50 micrograms VIP (expt 2, n = 10) administered hourly as intravenous boluses between 2200 and 0100 on sleep electroencephalogram and secretion of plasma adreno corticotropic hormone, cortisol, growth hormone, and prolactin in humans. In experiment 2, the sleep cycles were decelerated during the first three cycles because of increased duration of both REM and non-REM sleep periods, and there was a tendency to increased REM-to-non-REM ratios. With a low VIP dose, prolactin levels were decreased during the whole night, whereas, with a high dose, they were increased during the first half of the night. In experiment 2, the cortisol nadir was advanced, after midnight the serum cortisol levels were enhanced, and the growth hormone peak was blunted. It appears that VIP may have a phase-advancing effect on sleep cycles and cortisol secretion, possibly through actions that involve the suprachiasmatic nucleus.

AB - Centrally administered vasoactive intestinal polypeptide (VIP) promotes rapid eye movement (REM) sleep in rats, rabbits, and cats. We studied the effect of 4 x 10 micrograms VIP (expt 1, n = 7) and 4 x 50 micrograms VIP (expt 2, n = 10) administered hourly as intravenous boluses between 2200 and 0100 on sleep electroencephalogram and secretion of plasma adreno corticotropic hormone, cortisol, growth hormone, and prolactin in humans. In experiment 2, the sleep cycles were decelerated during the first three cycles because of increased duration of both REM and non-REM sleep periods, and there was a tendency to increased REM-to-non-REM ratios. With a low VIP dose, prolactin levels were decreased during the whole night, whereas, with a high dose, they were increased during the first half of the night. In experiment 2, the cortisol nadir was advanced, after midnight the serum cortisol levels were enhanced, and the growth hormone peak was blunted. It appears that VIP may have a phase-advancing effect on sleep cycles and cortisol secretion, possibly through actions that involve the suprachiasmatic nucleus.

M3 - SCORING: Zeitschriftenaufsatz

VL - 271(4 Pt 2)

SP - 905

EP - 911

JO - AM J PHYSIOL-HEART C

JF - AM J PHYSIOL-HEART C

SN - 0363-6135

ER -